Literature DB >> 32363431

Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project.

Virginia Boccardi1, Valentina Bubba2, Ilenia Murasecco2, Martina Pigliautile2, Roberto Monastero3, Roberta Cecchetti2, Michela Scamosci2, Patrizia Bastiani2, Patrizia Mecocci2.   

Abstract

BACKGROUND: Alkaline phosphatase has been found on neuronal membranes and plasma alkaline phosphatase (ALP) activity increases during brain injury and cerebrovascular diseases, suggesting that its levels may reflect the neuronal loss. It is known that ALP is higher in subjects affected by Alzheimer's dementia and inversely correlated with cognitive functions. No study has investigated the relationship between ALP and cognitive functions in old-age subject with pre-clinical cognitive impairment.
METHODS: This is a cross-sectional study with data gathered from the ReGAl 2.0 project (Rete Geriatrica Alzheimer-Geriatric Network on Alzheimer's disease), a large Italian multicentric clinical-based study. A cohort of 209 old-age subjects healthy controls (HC), Subjective cognitive decline (SCD), and Mild Cognitive Impairment (MCI) was included in the study. Cognitive performances were assessed with a large neuropsychological battery. The same day, serum alkaline phosphatase activity was measured in all subjects.
RESULTS: We found that the SCD group had significantly higher ALP levels as compared with HC (p = 0.001). Among all neuropsychological tests, in all population ALP levels negatively correlated with scores at attentional matrices (r =  - 0.243, p = 0.002), Digit Span Forward (r =  - 0.241, p = 0.003) and Letter Fluency Test (r =  - 0.196, p = 0.044). Attentional Matrices (r =  - 0.208, p = 0.014) and Letter Fluency Test (r =  - 0.229, p = 0.019) remained significantly correlated with ALP even after controlling for gender. In the SCD group, only the Attentional Matrices significantly and negatively correlated with ALP (r =  - 0.344 p = 0.035), while no significant correlations were found in HC or MCI.
CONCLUSIONS: Results indicate that serum alkaline phosphatase activity is increased in SCD and inversely correlates with cognitive functions. Further studies are needed to investigate the role of ALP in the progression to AD.

Entities:  

Keywords:  Aging; Biochemistry; Cognition; Dementia; Geriatric medicine

Year:  2020        PMID: 32363431     DOI: 10.1007/s40520-020-01572-6

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  15 in total

1.  Construct validity of the Babcock Story Recall Test.

Authors:  Michael David Horner; Gordon Teichner; Kathleen Bechtold Kortte; Richard T Harvey
Journal:  Appl Neuropsychol       Date:  2002

2.  The backward span of the Corsi Block-Tapping Task and its association with the WAIS-III Digit Span.

Authors:  Roy P C Kessels; Esther van den Berg; Carla Ruis; Augustina M A Brands
Journal:  Assessment       Date:  2008-05-15

3.  Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function.

Authors:  Katherine Ab Kellett; Jonathan Williams; Emma Rlc Vardy; A David Smith; Nigel M Hooper
Journal:  Int J Mol Epidemiol Genet       Date:  2011-02-10

4.  Prevalence and Correlates of Behavioral Disorders in Old Age Subjects with Cognitive Impairment: Results from the ReGAl Project.

Authors:  Virginia Boccardi; Manuela Conestabile Della Staffa; Marta Baroni; Sara Ercolani; Michele Francesco Croce; Carmelinda Ruggiero; Patrizia Mecocci
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Alkaline phosphatase is increased in both brain and plasma in Alzheimer's disease.

Authors:  Emma R L C Vardy; Katherine A B Kellett; Sarah L Cocklin; Nigel M Hooper
Journal:  Neurodegener Dis       Date:  2011-10-20       Impact factor: 2.977

6.  The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery.

Authors:  G A Carlesimo; C Caltagirone; G Gainotti
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

7.  Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau.

Authors:  Miguel Díaz-Hernández; Alberto Gómez-Ramos; Alicia Rubio; Rosa Gómez-Villafuertes; José R Naranjo; M Teresa Miras-Portugal; Jesús Avila
Journal:  J Biol Chem       Date:  2010-07-15       Impact factor: 5.157

Review 8.  Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component.

Authors:  Ramón Cacabelos; Lucía Fernández-Novoa; Lola Corzo; Luís Amado; Victor Pichel; Valter Lombardi; Yasuhiko Kubota
Journal:  Neurol Res       Date:  2004-07       Impact factor: 2.448

9.  Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project.

Authors:  E Mariani; R Monastero; S Ercolani; P Rinaldi; F Mangialasche; E Costanzi; D F Vitale; U Senin; P Mecocci
Journal:  Int J Geriatr Psychiatry       Date:  2008-05       Impact factor: 3.485

Review 10.  From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution.

Authors:  Yu-Wen Cheng; Ta-Fu Chen; Ming-Jang Chiu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-02-16       Impact factor: 2.570

View more
  5 in total

1.  The correlation between serum total alkaline phosphatase and bone mineral density in young adults.

Authors:  Juntao Shu; Anjun Tan; Yan Li; Hong Huang; Jingjing Yang
Journal:  BMC Musculoskelet Disord       Date:  2022-05-18       Impact factor: 2.562

Review 2.  Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease.

Authors:  Mathias Haarhaus; Giuseppe Cianciolo; Simona Barbuto; Gaetano La Manna; Lorenzo Gasperoni; Giovanni Tripepi; Mario Plebani; Maria Fusaro; Per Magnusson
Journal:  Nutrients       Date:  2022-05-19       Impact factor: 6.706

3.  Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.

Authors:  Jeffrey Cummings; Gregory G Schwartz; Stephen J Nicholls; Aziz Khan; Chris Halliday; Peter P Toth; Michael Sweeney; Jan O Johansson; Norman C W Wong; Ewelina Kulikowski; Kamyar Kalantar-Zadeh; Kenneth Lebioda; Henry N Ginsberg; Bengt Winblad; Henrik Zetterberg; Kausik K Ray
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

4.  Analysis of neuropathological comorbid conditions in elderly patients with mild cognitive impairment in a tertiary care center in South India.

Authors:  Alex Baby Paul; Dakshin Sitaram Padmanabhan; Vineeth Suresh; Sunav Nellai Nayagam; Niveditha Kartha; George Paul; Priya Vijayakumar
Journal:  J Family Med Prim Care       Date:  2022-03-18

5.  Cognitive and biological effects of citrus phytochemicals in subjective cognitive decline: a 36-week, randomized, placebo-controlled trial.

Authors:  Samantha Galluzzi; Roberta Zanardini; Clarissa Ferrari; Sara Gipponi; Ilaria Passeggia; Michela Rampini; Giovanni Sgrò; Salvatore Genovese; Serena Fiorito; Lucia Palumbo; Michela Pievani; Giovanni B Frisoni; Francesco Epifano
Journal:  Nutr J       Date:  2022-10-17       Impact factor: 4.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.